{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE297nnn/GSE297439/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Transcriptomics"],"species":["Homo sapiens"],"gds_type":["Expression profiling by high throughput sequencing"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297439"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"Rifamycin O as a Novel CRBN Ligand for Targeted Degradation of IKZF1/3 Proteins in Hematopoietic Malignancies","description":"We found that Rifamycin O could effectively suppressed the hematologic tumors growth in vitro and in vivo. The antitumor effect of Rifamycin O is first identified so far.","dates":{"publication":"2026/05/01"},"accession":"GSE297439","cross_references":{"GSM":["GSM8991781","GSM8991782","GSM8991783","GSM8991784","GSM8991785","GSM8991786"],"GPL":["24676"],"GSE":["297439"],"taxon":["Homo sapiens"],"PMID":["[41584346]"]}}